catzlab

SERGIO D. CATZ

Molecular and Experimental Medicine
Associate Professor

Education
B.S.c. University of Buenos Aires 1991
Ph.D. University of Buenos Aires 1997

Contact

The Scripps Research Institute
Department of Molecular and Experimental Medicine
10550 North Torrey Pines Road, MEM-280
La Jolla, CA, 92037
Phone: (858)-784-7932
Fax: (858)-784-2054
Email: scatz@scripps.edu



Scientific Interest

The mechanism underlying neutrophil exocytosis

Exocytosis in neutrophils is a crucial event in inflammation and innate immune response. Neutrophils contain four types of secretory organelles that hold a variety of specialized proteins which are essential for the microbicidal activity of these cells. The hierarchy that characterizes the secretory process of these granules correlates with the different roles of their cargo proteins in the processes of adhesion, migration, chemotaxis, phagocytosis and the production of reactive oxygen species. Tight regulation of the exocytic process is especially necessary in neutrophils because unrestricted release of the toxic content of their granules is injurious to the host.

The small GTPase Rab27a plays a central role in the regulation of exocytosis. Rab27a is the only Rab directly associated with a human genetic disease, Griscelli syndrome (GS). Patients with GS develop an immunodeficiency disorder characterized by malfunction of cytotoxic T-lymphocytes and impaired natural killer cell function. We have recently shown that Rab27a and its counterpart effectors ¬¬coordinate the exocytic dynamics of neutrophil granules. Our future studies aim to elucidate the differential mechanisms underlying the regulation of granule mobilization to the plasma membrane or to the phagosome using genetic and cellular biology approaches. Our long-term goal is to develop molecular therapeutic strategies to prevent uncontrolled release of neutrophil granule cargo proteins.

Vesicular trafficking in lysosomal storage disease (LSD)

LSD are genetic or acquired diseases characterized by anomalous accumulation of metabolites in the lysosomes. Increased levels of intralysosomal metabolites leads to cell malfunction and cell death. We have special interest in developing strategies directed at upregulating the vesicular trafficking pathways of cells that have accumulated metabolites in their lysosomes to restore normal cellular function and prevent cell death. We are currently exploring several trafficking pathways and utilizing high-throughput screening approaches to identify potential novel therapies for the treatment of LSDs.

Understanding Toll-like receptor signaling to improve the innate immune response to polymicrobial infections

Increasing evidence indicates the importance of mixed bacterial infections in the modulation of the pathogenicity of the individual bacterial strains, the concomitant host response, and the course and outcome of infectious diseases. Evidence suggests that during mixed infections the pathophysiology of one microorganism is affected by the co-infecting bacteria. Little is known about how the microorganisms modulate the host immune response during mixed infections.

Our research is directed at understanding the molecular mechanisms that regulate the neutrophil response during mixed infections. In particular, we examine the TLR-signaling involved in this regulation, and dissect the signaling mechanisms that mediate synergism or tolerance during mixed infections.

Other scientific Interests

  • Neutrophil extracellular traps (Nets)
  • NADPH Oxidase
  • Immunological synapse
  • Exocytosis in non-inflammatory cells (prostate carcinoma cells, RPE)
  • Prostate cancer
  • Transcriptional Regulation
  • Signal transduction and phosphoinositides

Past and Present Lab Members

  • Jennifer L. Johnson Ph.D (England)
  • Sandrine Pacquelet, PhD. (France)
  • Daniela B. Munafo, Ph.D. (Argentina)
  • Meeyoung Park, Ph.D. (South Korea)
  • Agnieszka A. Brzezinska, Ph.D. (Poland)
  • Beverly A. Ellis (USA)
  • Hong Hong (China)
  • Jlenia Monfregola (Italy)
  • Carol Taylor Administrative Assistant (858)-784-8095

Selected Publications (for complete list of publications please refer to www.pubmed.gov)

Johnson JL, Hong H, Monfregola J, Catz SD.  Increased survival and reduced neutrophil infiltration  of the liver in Rab27a- but not Munc13-4-deficient mice in LPS-induced systemic inflammation.  Infection & Immunity, 2011; PMID: 21746860

Johnson JL, Hong H, Monfregola J, Kiosses WB, and Catz SD. MUNC13-4 restricts motility of RAB27A-expressing vesicles to facilitate lipopolysaccharide-induced priming of exocytosis in neutrophils. J. Biol. Chem., 2011 286(7):5647-56

Johnson JL, Brzezinska AA, Tolmachova T, Munafo DB, Ellis BA, Seabra MC, Hong H, Catz SD. Rab27a and Rab27b Regulate Neutrophil Azurophilic Granule Exocytosis and NADPH oxidase Activity by Independent Mechanisms. Traffic, 2010; 11, 533-547

Daniela B. Munafo, Jennifer L. Johnson, Agnieszka A. Brzezinska, Beverly A. Ellis, Malcolm   
R. Wood and Catz SD. DNase I inhibits a late phase of reactive oxygen species production in neutrophils. J Innate Immunity 2009; 1:527–542

Agnieszka A. Brzezinska, Jennifer L. Johnson, Daniela B. Munafo, Beverly A. Ellis and Catz.S.D Signaling mechanisms for Toll-like receptor-activated neutrophil exocytosis: key roles for IRAK-4 and PI3-kinase but not TRIF. Immunology, 2009; 127(3):386-97 

Agnieszka A. Brzezinska, Jennifer L. Johnson, Daniela B. Munafo, Karine Crozat, Bruce Beutler, William B. Kiosses, Beverly A. Ellis and Catz S.D The Rab27a effectors JFC1/Slp1 and Munc13-4 regulate exocytosis of neutrophil granules. Traffic, 2008; 9: 2151–2164

Catz S.D. Characterization of Rab27a and JFC1 as constituents of the secretory machinery of prostate-specific antigen in prostate carcinoma cells. Methods in Enzymology, 2008; 438: 25-40

Pacquelet S, Johnson JL, Ellis BA, Brzezinska AA, Lane WS, Munafo DB and Catz S.D. (2007) Cross-talk between IRAK-4 and the NADPH oxidase. Biochemical Journal. 403(3):451-61.

Munafó DB, Johnson JL, Ellis BA, Rutschmann S, Beutler B and Catz S.D. (2007) Rab27a is a key component of the secretory machinery of azurophilic granules in granulocytes. Biochemical Journal. 402(2):229-39

J.L. Johnson, B.A. Ellis, D. Noack, M.C. Seabra and Catz, S.D. (2005). The Rab27a-binding protein, JFC1, regulates androgen-dependent secretion of prostate-specific antigen and prostatic-specific acid phosphatase. Biochemical Journal. 391: 699–710.

J. L. Johnson, S. Pacquelet, W.S. Lane, B. Eam and Catz, S.D. (2005) Akt Regulates the Subcellular Localization of the Rab27a-Binding Protein JFC1 by Phosphorylation. Traffic 6(8):667-81.

Catz, S.D., Johnson, J.L. & Babior, B.M. (2002) The C2A domain of JFC1 binds to 3’-phosphorylated phosphoinositides and directs plasma membrane association in living cells. Proc.Natl.Acad.Sci.U.S.A. 99(18):11652-11657.

Catz, S.D., Babior, B.M. & Johnson, J.L. (2002) JFC1 is transcriptionally activated by nuclear factor kappaB and up-regulated by tumor necrosis factor alpha in prostate carcinoma cells. Biochemical Journal, 367:791-9.

Catz, S.D. & Johnson, J.L. (2001) Transcriptional regulation of bcl-2 by nuclear factor kappaB and its significance in prostate cancer. Oncogene, 20, 7342-7351.

.